Evidence map›Paper›PMID 39533234›Full record

ArticleBMC pediatrics2024

A case of pioneering subcutaneous implantable cardioverter defibrillator intervention in Timothy syndrome.

Zixi Zhang, Keke Wu, Zhihong Wu, Yunbin Xiao, Yefeng Wang, Qiuzhen Lin, Cancan Wang, Qingyi Zhu, Yichao Xiao, Qiming Liu

Abstract readCase Reports
In one paragraph

Article in BMC pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zixi Zhang *Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Changsha, 410011, Hunan Province, People's Republic of China.
Keke Wu *Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Changsha, 410011, Hunan Province, People's Republic of China.
Zhihong WuDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Changsha, 410011, Hunan Province, People's Republic of China.
Yunbin XiaoDepartment of Cardiology, Hunan Children's Hospital, Central South University, Changsha, Hunan Province, People's Republic of China.
Yefeng WangDepartment of Cardiology, Hunan Children's Hospital, Central South University, Changsha, Hunan Province, People's Republic of China.
Qiuzhen LinDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Changsha, 410011, Hunan Province, People's Republic of China.
Cancan WangFirst Clinical College, Changsha Medical University, Changsha, 410219, Hunan Province, People's Republic of China.
Qingyi ZhuDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Changsha, 410011, Hunan Province, People's Republic of China. zhuqingyi@csu.edu.cn.
Yichao XiaoDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Changsha, 410011, Hunan Province, People's Republic of China. yichaoxiao@csu.edu.cn.
Qiming LiuDepartment of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Furong District, Changsha, 410011, Hunan Province, People's Republic of China. qimingliu@csu.edu.cn.

Funding

Clinical Medical Technology Innovation Guidance Project of Hunan Science and Technology Agency 2021SK53519Hunan Provincial Natural Science Foundation of China 2021JJ30033Key Project of Hunan Provincial Science and Technology Innovation 2020SK1013National Natural Science Foundation of China 82070356
6 · The paper itself

Abstract

This case report presents a notable instance of subcutaneous implantable cardioverter defibrillator (S-ICD) implantation in a 9-year-old patient diagnosed with Timothy syndrome (TS), which is a rare condition characterized by mutations in the CACNA1c gene. Conventional therapies often have limited efficacy in managing TS. This case is significant, as it represents the youngest age for S-ICD implantation recorded in mainland China. While the absence of ventricular arrhythmias during hospitalization and follow-up is encouraging, it is not sufficient to conclusively establish the safety and feasibility of this intervention in young TS patients. Further research is needed to evaluate the long-term outcomes and to consider S-ICD as a potential standard treatment option for TS. Additionally, there is a need for a more detailed exploration of the molecular mechanisms underlying gene therapy and personalized interventions.

Indexed as

Autistic DisorderDefibrillators, ImplantableLong QT SyndromeSyndactylyChildHumansCase reportLong QTSubcutaneous implantable cardioverter defibrillator (S-ICD)Timothy syndromeVentricular arrhythmias

Identifiers

PMID39533234
PMCPMC11558885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.